Prothena | PRTA - Le Bénéfice D'Exploitation

Prix De L'Action
10.75
Variation Quotidienne
0.02 0.19%
Mensuellement
15.47%
Annuel
10.82%
Q2 Prévisions
10.43




Le Bénéfice D'Exploitation Changement Date
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Akebia Therapeutics USD -5.45M 9.4M 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Immunic USD -25.73M 2.91M 2024-09
Incyte USD 383.88M 47.43M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
MacroGenics USD -12.1M 30.74M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Prothena USD -27.21M 12.55M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Xoma USD -15.64M 5.56M 2024-09